Crawford Announces New Ad Policy Group, Defends FDA Court Interventions
This article was originally published in The Gray Sheet
Executive Summary
An FDA intercenter coordinating group will oversee medical product advertising to ensure it is properly regulated, according to Acting Commissioner Lester Crawford, PhD/DVM
You may also be interested in...
FDA Commish Pick Imminent? Crawford Finally May Shed Understudy Role
The White House seems to have selected FDA Acting Commissioner Lester Crawford, PhD/DVM, as its choice to fill the commissioner slot on a permanent basis
Promotion Steering Committee In Planning Stage – FDA Ad Division Official
FDA's intercenter Promotion Steering Committee will include senior officials from the device, drug and biologics centers, along with representatives from the chief counsel's and commissioner's offices, according to Center for Drug Evaluation & Research ad division director Tom Abrams
Promotion Steering Committee In Planning Stage – FDA Ad Division Official
FDA's intercenter Promotion Steering Committee will include senior officials from the device, drug and biologics centers, along with representatives from the chief counsel's and commissioner's offices, according to Center for Drug Evaluation & Research ad division director Tom Abrams